Neuberger Berman Group’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,049
Closed -$4.18M 2122
2025
Q3
$4.18M Sell
21,049
-2,185
-9% -$408K ﹤0.01% 1005
2025
Q2
$4.01M Sell
23,234
-23,096
-50% -$3.76M ﹤0.01% 1019
2025
Q1
$7.22M Buy
46,330
+8,201
+22% +$1.17M 0.01% 848
2024
Q4
$5.25M Sell
38,129
-1,633
-4% -$215K ﹤0.01% 953
2024
Q3
$5.94M Buy
39,762
+9,466
+31% +$1.28M ﹤0.01% 909
2024
Q2
$4.13M Buy
+30,296
New +$4.12M ﹤0.01% 946
2021
Q2
Sell
-190,900
Closed -$24.6M 1754
2021
Q1
$24.6M Buy
190,900
+60,400
+46% +$9.18M 0.02% 630
2020
Q4
$21.8M Buy
130,500
+2,500
+2% +$413K 0.02% 620
2020
Q3
$19.8M Buy
128,000
+22,000
+21% +$3.16M 0.02% 583
2020
Q2
$15.7M Buy
106,000
+46,500
+78% +$6.38M 0.02% 622
2020
Q1
$6.7M Sell
59,500
-5,169
-8% -$672K 0.01% 743
2019
Q4
$9M Buy
+64,669
New +$7.18M 0.01% 763
2018
Q2
Sell
-14,000
Closed -$916K 1703
2018
Q1
$916K Buy
+14,000
New +$787K ﹤0.01% 1201

Other funds holding ASND